Megan L. Fitzgerald, Alison K. Cohen, Toni Wall Jaudon, Julia Moore Vogel, Abigail N. Koppes, Lucia Santos, Rachel Robles, Jerry Lin, J.D. Davids, Chris McWilliams, Signe Redfield, Kathleen P. Banks, Maria Richardson, Teresa T. Tindle Akintonwa, Beth Pollack, Ezra Spier, Aimee Weiss, Gina Assaf, Hannah Davis, Lisa McCorkell
{"title":"患者研究人员呼吁推进长 COVID 研究","authors":"Megan L. Fitzgerald, Alison K. Cohen, Toni Wall Jaudon, Julia Moore Vogel, Abigail N. Koppes, Lucia Santos, Rachel Robles, Jerry Lin, J.D. Davids, Chris McWilliams, Signe Redfield, Kathleen P. Banks, Maria Richardson, Teresa T. Tindle Akintonwa, Beth Pollack, Ezra Spier, Aimee Weiss, Gina Assaf, Hannah Davis, Lisa McCorkell","doi":"10.1016/j.cell.2024.09.011","DOIUrl":null,"url":null,"abstract":"Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.","PeriodicalId":9656,"journal":{"name":"Cell","volume":null,"pages":null},"PeriodicalIF":45.5000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A call from patient-researchers to advance research on long COVID\",\"authors\":\"Megan L. Fitzgerald, Alison K. Cohen, Toni Wall Jaudon, Julia Moore Vogel, Abigail N. Koppes, Lucia Santos, Rachel Robles, Jerry Lin, J.D. Davids, Chris McWilliams, Signe Redfield, Kathleen P. Banks, Maria Richardson, Teresa T. Tindle Akintonwa, Beth Pollack, Ezra Spier, Aimee Weiss, Gina Assaf, Hannah Davis, Lisa McCorkell\",\"doi\":\"10.1016/j.cell.2024.09.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.\",\"PeriodicalId\":9656,\"journal\":{\"name\":\"Cell\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":45.5000,\"publicationDate\":\"2024-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/j.cell.2024.09.011\",\"RegionNum\":1,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.cell.2024.09.011","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
A call from patient-researchers to advance research on long COVID
Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.
期刊介绍：
Cells is an international, peer-reviewed, open access journal that focuses on cell biology, molecular biology, and biophysics. It is affiliated with several societies, including the Spanish Society for Biochemistry and Molecular Biology (SEBBM), Nordic Autophagy Society (NAS), Spanish Society of Hematology and Hemotherapy (SEHH), and Society for Regenerative Medicine (Russian Federation) (RPO).
The journal publishes research findings of significant importance in various areas of experimental biology, such as cell biology, molecular biology, neuroscience, immunology, virology, microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. The primary criterion for considering papers is whether the results contribute to significant conceptual advances or raise thought-provoking questions and hypotheses related to interesting and important biological inquiries.
In addition to primary research articles presented in four formats, Cells also features review and opinion articles in its "leading edge" section, discussing recent research advancements and topics of interest to its wide readership.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
